The US Food and Drug Administration on Thursday authorized Merck’s antiviral pill, molnupiravir, to treat Covid-19 “for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death, and for whom alternative COVID-19 treatment options authorized by the FDA are not accessible or clinically appropriate.”
[su_button url=’https://www.cnn.com/2021/12/22/health/pfizer-antiviral-pill-authorized/index.html’ target=’span’ style=’ghost’ background=’#c91010′ color=’#c91010′ size=’2′ wide=’no’ center=’no’ radius=’auto’]Read the full story at CNN[/su_button]
By
By
By
By
By
By
